Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Operating Expenses | 1,617 | 997 | 0 |
| Operating Income | -1,617 | -997 | N/A |
| Other Income | 805 | -14 | 0 |
| Pre-tax Income | -812 | -1,010 | 0 |
| Net Income Continuous | -812 | -1,010 | N/A |
| Net Income | $-812 | $-1,010 | $N/A |
| EPS Basic Total Ops | -157.80 | -169.60 | N/A |
| EPS Basic Continuous Ops | -53.74 | -66.96 | N/A |
| EPS Diluted Total Ops | -157.80 | -169.60 | N/A |
| EPS Diluted Continuous Ops | -53.74 | -66.96 | N/A |
| EBITDA(a) | $-1,482 | $-957 | $N/A |